The Role of Easy-to-use Non-invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis - Data from the Romanian Hepatocellular Carcinoma Registry.

IF 2
Dana Crișan, Bogdan Procopeț, Rareș Crăciun, Horia Ștefănescu, Liana Gheorghe, Ioan Sporea, Larisa Daniela Săndulescu, Anca Trifan, Zeno Spârchez, Mirela Dănilă, Ion Rogoveanu, Răzvan Cerban, Camelia Cojocariu, Roxana Șirli, Cristiana Marinela Urhut, Călin Burciu, Lidia Ciobanu, Mihai Rătan, Tudor Cosma, Nadim Al-Hajjar, Mircea Grigorescu
{"title":"The Role of Easy-to-use Non-invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis - Data from the Romanian Hepatocellular Carcinoma Registry.","authors":"Dana Crișan, Bogdan Procopeț, Rareș Crăciun, Horia Ștefănescu, Liana Gheorghe, Ioan Sporea, Larisa Daniela Săndulescu, Anca Trifan, Zeno Spârchez, Mirela Dănilă, Ion Rogoveanu, Răzvan Cerban, Camelia Cojocariu, Roxana Șirli, Cristiana Marinela Urhut, Călin Burciu, Lidia Ciobanu, Mihai Rătan, Tudor Cosma, Nadim Al-Hajjar, Mircea Grigorescu","doi":"10.15403/jgld-6114","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related mortality, a figure that is on the rise. The shared hallmark of different etiologies, progression, and HCC survival is chronic inflammation, making it a significant field of interest for prognostic and therapeutic strategies. We aimed to evaluate the prognostic accuracy of several inflammation-based scores in HCC.</p><p><strong>Methods: </strong>A consecutive series of patients at their first HCC diagnosis were enrolled during a 5-year timespan in a prospectively maintained multicentric database. Demographic, clinical, biological, and imagistic data were collected. Representative inflammation-based prognostic scores, including the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic immune inflammation index (SII), prognostic nutritional index (PNI), albumin-to-bilirubin index (ALBI), platelet-albumin-bilirubin-index (PALBI), AST-to-lymphocyte ratio (ALRI), AST/ALT, AST-to-platelet ratio (APRI) were assessed for prediction of overall survival (OS) in a scenario-based setting, using Kaplan-Meier curves, univariate and multivariate analyses.</p><p><strong>Results: </strong>A total of 467 patients from five tertiary-care hospitals were enrolled in this study. The median age was 64.94 years, and the most frequent etiology of the liver disease was hepatitis C (50%). During a median of 14.85 (35) months of follow-up, the cumulative mortality was 84.8%. In the univariate analysis, PNI (HR=2.414; p=0.021), ALBI grade (HR=2.023; p<0.001), and PALBI grade (HR=2.022; p<0.001) demonstrated the highest prognostic accuracies for OS in HCC, regardless of the clinical scenario. Moreover, PLR (HR=1.635; p=0.002), ALRI (HR=1.555; p<0.001), NLR (HR=1.461; p=0.007), AST/ALT (HR=1.420; p=0.012), and APRI (HR=1.356; p=0.009) were also significant prognostic factors for OS. The multivariate analysis showed that only ALBI grade (HR=1.974; p<0.001), SII (HR=1.487; p=0.009), and PLR (HR=1.647; p=0.014) were independently associated with OS.</p><p><strong>Conclusions: </strong>Inflammation-based scores allow for an accurate prediction of survival in HCC. Their ability to predict the response to treatment and complications merits further investigation.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"34 2","pages":"205-213"},"PeriodicalIF":2.0000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gastrointestinal and liver diseases : JGLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15403/jgld-6114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related mortality, a figure that is on the rise. The shared hallmark of different etiologies, progression, and HCC survival is chronic inflammation, making it a significant field of interest for prognostic and therapeutic strategies. We aimed to evaluate the prognostic accuracy of several inflammation-based scores in HCC.

Methods: A consecutive series of patients at their first HCC diagnosis were enrolled during a 5-year timespan in a prospectively maintained multicentric database. Demographic, clinical, biological, and imagistic data were collected. Representative inflammation-based prognostic scores, including the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic immune inflammation index (SII), prognostic nutritional index (PNI), albumin-to-bilirubin index (ALBI), platelet-albumin-bilirubin-index (PALBI), AST-to-lymphocyte ratio (ALRI), AST/ALT, AST-to-platelet ratio (APRI) were assessed for prediction of overall survival (OS) in a scenario-based setting, using Kaplan-Meier curves, univariate and multivariate analyses.

Results: A total of 467 patients from five tertiary-care hospitals were enrolled in this study. The median age was 64.94 years, and the most frequent etiology of the liver disease was hepatitis C (50%). During a median of 14.85 (35) months of follow-up, the cumulative mortality was 84.8%. In the univariate analysis, PNI (HR=2.414; p=0.021), ALBI grade (HR=2.023; p<0.001), and PALBI grade (HR=2.022; p<0.001) demonstrated the highest prognostic accuracies for OS in HCC, regardless of the clinical scenario. Moreover, PLR (HR=1.635; p=0.002), ALRI (HR=1.555; p<0.001), NLR (HR=1.461; p=0.007), AST/ALT (HR=1.420; p=0.012), and APRI (HR=1.356; p=0.009) were also significant prognostic factors for OS. The multivariate analysis showed that only ALBI grade (HR=1.974; p<0.001), SII (HR=1.487; p=0.009), and PLR (HR=1.647; p=0.014) were independently associated with OS.

Conclusions: Inflammation-based scores allow for an accurate prediction of survival in HCC. Their ability to predict the response to treatment and complications merits further investigation.

易于使用的非侵入性评分在肝细胞癌预后评估中的作用——来自罗马尼亚肝细胞癌登记处的数据。
背景和目的:肝细胞癌(HCC)目前是癌症相关死亡的第三大原因,这一数字正在上升。不同病因、进展和HCC生存的共同特征是慢性炎症,这使其成为预后和治疗策略的重要领域。我们的目的是评估几种基于炎症的HCC评分的预后准确性。方法:在一个前瞻性维护的多中心数据库中,在5年的时间跨度内连续纳入首次诊断为HCC的患者。收集了人口学、临床、生物学和影像学数据。基于炎症的代表性预后评分,包括血小板-淋巴细胞比率(PLR)、中性粒细胞-淋巴细胞比率(NLR)、全身免疫炎症指数(SII)、预后营养指数(PNI)、白蛋白-胆红素指数(ALBI)、血小板-白蛋白-胆红素指数(PALBI)、AST-淋巴细胞比率(ALRI)、AST/ALT、AST-血小板比率(APRI),在基于场景的环境中评估用于预测总生存期(OS)的Kaplan-Meier曲线。单变量和多变量分析。结果:本研究共纳入来自5家三级医院的467例患者。中位年龄为64.94岁,肝病最常见的病因是丙型肝炎(50%)。在中位14.85(35)个月的随访期间,累计死亡率为84.8%。单因素分析中,PNI (HR=2.414;p=0.021), ALBI分级(HR=2.023;结论:基于炎症的评分可以准确预测HCC患者的生存。它们预测治疗反应和并发症的能力值得进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信